Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.
Munzen ME, Reguera Gomez M, Hamed MF, Enriquez V, Charles-Niño CL, Dores MR, Alviña K, Martinez LR.
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0045923. doi: 10.1128/aac.00459-23. Epub 2023 Sep 26.
Cryptococcus neoformans, a global threat to human health.
Zhao Y, Ye L, Zhao F, Zhang L, Lu Z, Chu T, Wang S, Liu Z, Sun Y, Chen M, Liao G, Ding C, Xu Y, Liao W, Wang L.
Infect Dis Poverty. 2023 Mar 17;12(1):20. doi: 10.1186/s40249-023-01073-4.
[Cerebral cryptococcomas].
Woeffray MJ, Aguirre AR, Saguier Padilla I, Kinjo BL, Folgar SS, Mercado FCB.
Medicina (B Aires). 2024;84(4):793.
Infratentorial cerebral cryptococcosis.
Borresen TE, Hunter DR.
J Neuroimaging. 1995 Jan;5(1):48-9. doi: 10.1111/jon19955148.
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Ngan NTT, Flower B, Day JN.
Drugs. 2022 Aug;82(12):1237-1249. doi: 10.1007/s40265-022-01757-5. Epub 2022 Sep 16.
Brainstem Cryptococcoma.
Lan T, Wang Y.
World Neurosurg. 2025 Mar;195:123351. doi: 10.1016/j.wneu.2024.10.080. Epub 2024 Nov 25.
Cryptococcal meningitis.
Ming DK, Harrison TS.
Br J Hosp Med (Lond). 2017 Aug 2;78(8):C125-C127. doi: 10.12968/hmed.2017.78.8.C125.
Overwhelming cryptococcosis complicated by cryptococcal endocarditis.
Elkhatib W, Kwon JY, Phillips MB.
BMJ Case Rep. 2022 Mar 2;15(3):e247310. doi: 10.1136/bcr-2021-247310.
Cryptococcosis in AIDS.
Imwidthaya P, Poungvarin N.
Postgrad Med J. 2000 Feb;76(892):85-8. doi: 10.1136/pmj.76.892.85.
Treatment of cryptococcosis in non-HIV immunocompromised patients.
Henao-Martínez AF, Chastain DB, Franco-Paredes C.
Curr Opin Infect Dis. 2018 Aug;31(4):278-285. doi: 10.1097/QCO.0000000000000458.
